Equity · Healthcare
ANGO
NASDAQAngioDynamics (ANGO)
The line runs 15.66 USD on 17 August through 11.87 USD on 13 November, on a scale from 10 to 18. Days the market did not trade hold the previous close, flat.
- Market cap
- 499.0M USD
- Revenue, year to May 2026
- 320.2M USD
- EPS, diluted, year to May 2026
- −0.88 USD
- 52-week range
- 9.70 USD – 16.08 USD
- Avg volume
- 71.3K
as of Nov 13, 2026
Have AngioDynamics (ANGO) insiders bought or sold shares recently?
In the 90 days to 15 Nov 2026, AngioDynamics insiders reported 2 open-market sales and no purchases (SEC Form 4); none has bought on the open market since 21 Oct 2025.
Form 4, 90 days to 15 Nov 2026, newest reported trade 29 Oct 2026
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 29 Oct 2026 | Trowbridge Stephen AEVP and CFO | Sell | 23,615 | 290K USD |
| 28 Oct 2026 | Trowbridge Stephen AEVP and CFO | Sell | 1,720 | 21K USD |
| Sold | 2 open-market sales | 25,335 | $311K |
1 other filing in the window: a grant, exercise, tax withholding or transfer, not a trade
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 02 Nov 2026 | Honroth EricPresident and CEO | Award | 101,193 |
Which funds hold AngioDynamics (ANGO)?
2 of the 45 institutional funds we track reported a AngioDynamics position for the quarter ended 30 Sep 2026 — a combined 18.8M USD; the latest of those filings landed 13 Nov 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Renaissance Technologies | Held (±25%) | 620,383 | 9.5M USD | −15.5% |
| Marshall Wace | Added | 605,234 | 9.3M USD | +44.0% |
Have members of Congress traded AngioDynamics (ANGO)?
The most recent congressional trade disclosed in AngioDynamics is a sale by Debbie Wasserman Schultz (house, FL), dated 16 Jul 2025.
STOCK Act disclosures
| Traded | Member | Type | Amount | Filed after |
|---|---|---|---|---|
| 16 Jul 2025 | Debbie Wasserman Schultzhouse · Democrat–FL | Sale | 1K USD–15K USD | 9 days |
| 27 Jun 2025 | Debbie Wasserman Schultzhouse · Democrat–FL | Purchase | 1K USD–15K USD | 28 days |
What has been filed or recorded for AngioDynamics (ANGO)?
The filings we hold for AngioDynamics, newest first: 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 31 Aug 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 31 Aug 2026 | Quarterly earnings | Q1 2027 reported | EPS −0.17 USD | |
| 31 Aug 2026 | Financials | Total assets | 241.9M USD | at period end |
| 31 Aug 2026 | Financials | Total equity | 164.0M USD | at period end |
| 31 May 2026 | Annual report | FY 2026 reported | EPS −0.88 USD | |
| 31 May 2026 | Financials | Revenue | 320.2M USD | fiscal year |
| 31 May 2026 | Financials | Net income | −36.7M USD | fiscal year |
| 31 May 2026 | Financials | Diluted EPS | −0.88 USD | fiscal year |
| 28 Feb 2026 | Quarterly earnings | Q3 2026 reported | EPS −0.19 USD | |
| 30 Nov 2025 | Quarterly earnings | Q2 2026 reported | EPS −0.15 USD | |
| 31 Aug 2025 | Quarterly earnings | Q1 2026 reported | EPS −0.26 USD | |
| 31 May 2025 | Annual report | FY 2025 reported | EPS −0.83 USD | |
| 28 Feb 2025 | Quarterly earnings | Q3 2025 reported | EPS −0.11 USD | |
| 30 Nov 2024 | Quarterly earnings | Q2 2025 reported | EPS −0.26 USD |
What do people ask about AngioDynamics (ANGO)?
What did AngioDynamics shares close at?11.87
AngioDynamics closed at 11.87 USD on 13 Nov 2026, down 0.96% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is AngioDynamics’ market cap?499.0M
AngioDynamics is worth 499.0M USD by market value as of 13 Nov 2026, which is the share price times the shares on issue from its SEC filings.
What is AngioDynamics’ revenue?320.2M
AngioDynamics reported revenue of 320.2M USD for the year ended 31 May 2026, as filed with the SEC. See Filings
Have AngioDynamics insiders bought or sold shares recently?2 sales
In the 90 days to 15 Nov 2026, AngioDynamics insiders reported 2 open-market sales and no purchases (SEC Form 4); none has bought on the open market since 21 Oct 2025. A further 1 filing was a grant, award, gift or exercise rather than an open-market trade. See Insiders
Which funds own AngioDynamics?2 of 45
2 of the 45 funds we track reported a AngioDynamics position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported positions were Renaissance Technologies and Marshall Wace. See Funds
Have members of Congress traded AngioDynamics?2 trades
Yes. 2 trades in AngioDynamics appear in the congressional disclosures we hold; the latest is a sale by Debbie Wasserman Schultz (House, FL) dated 16 Jul 2025, filed 25 Jul 2025. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress
When did AngioDynamics last report earnings?−0.17
AngioDynamics last reported earnings on 31 Aug 2026 for Q1 2027, with EPS of −0.17 USD; no next date is announced in SEC filings yet. See Filings
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- Wikimedia CommonsPortraits via Wikimedia Commons. Debbie Wasserman Schultz: U.S. Congress, Public domain.
- House disclosuresU.S. House of Representatives financial disclosures
- SEC EDGARXBRL company facts, latest period ended 31 Aug 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings